CDC developing anti-HIV vaginal gel for use after sex
Tests in monkeys show a gel containing an HIV drug stops the virus from infecting cells -- even if applied after sex, U.S. researchers say. Dr. Walid Heinene of the Centers for Disease Control and Prevention in Atlanta tested
a gel containing the human immunodeficiency virus drug raltegravir. The gel protected monkeys when given before they were infected with HIV vaginally, but it also prevented infection when applied as long as 3 hours after sex, NBC News reported.
If the gel has a similar impact in humans, women would be able protect themselves from HIV infection after sexual intercourse, Heinene said.
The HIV virus that causes AIDS can be transmitted in blood, semen and breast milk, but most people are infected sexually and in Africa, where most cases occur, 60 percent of HIV patients are women. Almost all were infected by husbands or other sexual partners, Heinene said.
Source: UPI
GMT 08:36 2018 Tuesday ,23 January
Sanofi buys US haemophilia treatment firmGMT 09:49 2018 Monday ,22 January
Health sector reforms remove capacity constrainsGMT 06:46 2018 Friday ,19 January
Rising Yemen currency sparks hope of relief for millionsGMT 12:34 2018 Tuesday ,16 January
On Obstetrics, Gynecology and Infertility begins tomorrowGMT 07:45 2018 Sunday ,14 January
'Hundreds' of lawsuits filed over Lactalis salmonellaGMT 11:08 2018 Friday ,12 January
Philippines: deaths in vaccine row 'consistent with' dengueGMT 09:28 2018 Wednesday ,10 January
Trump marijuana policy reversal stokes fearsGMT 09:35 2018 Monday ,08 January
Trump marijuana policy reversal stokes fearsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©